Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

AERIE PHARMACEUTICALS INC (AERI) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/21/2022 4 McHugh Julie (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 16,095 shares @ $15.25, valued at $245.4k
Disposed/sold 7,800 options to buy @ $13.27, valued at $103.5k
Disposed/sold 16,854 options to buy @ $6.11, valued at $103k
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 McDonnell Peter J (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 7,995 shares @ $15.25, valued at $121.9k
Disposed/sold 16,854 options to buy @ $6.11, valued at $103k
11/21/2022 4 Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 280,244 shares @ $15.25, valued at $4.3M
Disposed/sold 25,000 options to buy @ $3.15, valued at $78.8k
Disposed/sold 65,941 options to buy @ $8.8, valued at $580.3k
11/21/2022 4 Lang Peter Frederick (CFO) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 46,297 shares @ $15.25, valued at $706k
Disposed/sold 160,551 options to buy @ $8.8, valued at $1.4M
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 11,495 shares @ $15.25, valued at $175.3k
Disposed/sold 1,996 shares @ $15.25, valued at $30.4k
Disposed/sold 7,800 options to buy @ $13.27, valued at $103.5k
Disposed/sold 16,854 options to buy @ $6.11, valued at $103k
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Calabrese Jeffrey (Vice President of Finance) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 18,585 shares @ $15.25, valued at $283.4k
Disposed/sold 6,257 options to buy @ $11.02, valued at $69k
Disposed/sold 20,774 options to buy @ $8.36, valued at $173.7k
11/21/2022 4 KANNAN RAJ (CEO) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Disposed/sold 215,783 shares @ $15.25, valued at $3.3M
Disposed/sold 387,169 options to buy @ $8.11, valued at $3.1M
Disposed/sold 197,239 options to buy @ $8.8, valued at $1.7M
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 McHugh Julie (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 6,245 shares @ $0
Granted 16,854 options to buy @ $6.11, valued at $103k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 McDonnell Peter J (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 6,245 shares @ $0
Granted 16,854 options to buy @ $6.11, valued at $103k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 du Toit Michael (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 6,245 shares @ $0
Granted 16,854 options to buy @ $6.11, valued at $103k
06/13/2022 4 Croarkin Richard (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 6,245 shares @ $0
Granted 16,854 options to buy @ $6.11, valued at $103k
03/22/2022 4 Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 19,015 shares @ $0
Granted 65,941 options to buy @ $8.8, valued at $580.3k
03/22/2022 4 LaRocca John (General Counsel) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 19,015 shares @ $0
Granted 65,941 options to buy @ $8.8, valued at $580.3k
03/22/2022 4 KANNAN RAJ (CEO) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 197,239 options to buy @ $8.8, valued at $1.7M
03/22/2022 4 Lang Peter Frederick (CFO) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 46,297 shares @ $0
Granted 160,551 options to buy @ $8.8, valued at $1.4M
03/22/2022 3 Lang Peter Frederick (CFO) has filed a Form 3 on AERIE PHARMACEUTICALS INC
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 LaRocca John (General Counsel) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,973 shares @ $6, valued at $11.8k
02/09/2022 4 Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 701 shares @ $7.24, valued at $5.1k
Paid exercise price by delivering 700 shares @ $7.33, valued at $5.1k
02/09/2022 4 LaRocca John (General Counsel) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 768 shares @ $7.24, valued at $5.6k
02/09/2022 4 MITRO THOMAS A (President and COO) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,310 shares @ $7.24, valued at $9.5k
Paid exercise price by delivering 1,111 shares @ $7.33, valued at $8.1k
02/08/2022 4 Hollander David (Chief R&D Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 927 shares @ $7.05, valued at $6.5k
02/08/2022 4 Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 963 shares @ $7.05, valued at $6.8k
Paid exercise price by delivering 876 shares @ $7.05, valued at $6.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy